跳至主要内容
临床试验/CTRI/2025/07/091107
CTRI/2025/07/091107尚未招募不适用

Diagnostic And Prognostic significance of Presepsin, Procalcitonin and Interleukin-6 in Sepsis

Maulana Azad Medical College1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年7月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
Serum Presepsin, PCT and IL-6 in adults with sepsis and non infectious organ failure.

研究概览

简要总结

This study will be done to find diagnostic and prognostic significance of Presepsin, Procalcitonin and Interleukin-6 in sepsis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • First diagnosed at the time of admission with qSOFA score equals or more than 2 points according to sepsis 3 criteria no clinical suspicion of infection.

排除标准

  • Known cases of Acute coronary syndrome Acute burn injuries Terminal cancer Estimated Glomerular filtration rate less than 60ml per min.

结局指标

主要结局

Serum Presepsin, PCT and IL-6 in adults with sepsis and non infectious organ failure.

时间窗: 6 months

次要结局

  • best predictor of outcome among Serum Presepsin, PCT and IL-6 in adults with sepsis(6 months)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr. Arpita Suri

Maulana azad medical college

研究点 (1)

Loading locations...

相似试验